| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |